SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on February 10, 2025, the Compensation…
Ad hoc announcement pursuant to Art. 53 LR The updated invitation to the bondholder meeting – scheduled for February 25,…
February 12, 2025 16:38 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals…
February 12, 2025 16:30 ET | Source: Jade Biosciences VANCOUVER, British Columbia and SAN FRANCISCO, Feb. 12, 2025 (GLOBE NEWSWIRE)…
HUNTSVILLE, AL, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing…
– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on…
Leading ABA Provider Set to Open Newest Location in Lincoln, NE. February 11, 2025 20:00 ET | Source: Lighthouse Autism…
February 11, 2025 18:15 ET | Source: Microbot Medical Inc. BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical…
February 11, 2025 17:30 ET | Source: AnaptysBio, Inc. SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:…
– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on…